These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 27545492

  • 1. The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Disease in Solid Organ Transplant Recipients: A Systematic Review.
    AlDabbagh MA, Gitman MR, Kumar D, Humar A, Rotstein C, Husain S.
    Am J Transplant; 2017 Mar; 17(3):770-781. PubMed ID: 27545492
    [Abstract] [Full Text] [Related]

  • 2. Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipients.
    Malouf MA, Chhajed PN, Hopkins P, Plit M, Turner J, Glanville AR.
    J Heart Lung Transplant; 2002 May; 21(5):547-54. PubMed ID: 11983544
    [Abstract] [Full Text] [Related]

  • 3. Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study.
    Walti LN, Mugglin C, Sidler D, Mombelli M, Manuel O, Hirsch HH, Khanna N, Mueller N, Berger C, Boggian K, Garzoni C, Neofytos D, van Delden C, Hirzel C, Swiss Transplant Cohort Study (STCS)Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland..
    Am J Transplant; 2021 Jul; 21(7):2532-2542. PubMed ID: 33289340
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder.
    Humar A, Hébert D, Davies HD, Humar A, Stephens D, O'Doherty B, Allen U.
    Transplantation; 2006 Mar 27; 81(6):856-61. PubMed ID: 16570008
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Case Report: Non-negligible Epstein-Barr virus-associated posttransplant lymphoproliferative disorders in a lung transplant recipient.
    Hu J, Yu YW, Han DS, Li XJ, Zhang YQ, Cai HL, Xiao YH, Zheng X.
    Front Immunol; 2023 Mar 27; 14():1244534. PubMed ID: 37781359
    [Abstract] [Full Text] [Related]

  • 9. Clinical and virologic outcomes in high-risk adult Epstein-Barr virus mismatched organ transplant recipients.
    Kumar D, Patil N, Husain S, Chaparro C, Bhat M, Kim SJ, Humar A.
    Clin Transplant; 2017 Jul 27; 31(7):. PubMed ID: 28489256
    [Abstract] [Full Text] [Related]

  • 10. Impact of antiviral prophylaxis in adults Epstein-Barr Virus-seronegative kidney recipients on early and late post-transplantation lymphoproliferative disorder onset: a retrospective cohort study.
    Ville S, Imbert-Marcille BM, Coste-Burel M, Garandeau C, Meurette A, Cantarovitch D, Giral M, Hourmant M, Blancho G, Dantal J.
    Transpl Int; 2018 May 27; 31(5):484-494. PubMed ID: 29057508
    [Abstract] [Full Text] [Related]

  • 11. Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.
    McDiarmid SV, Jordan S, Kim GS, Toyoda M, Goss JA, Vargas JH, Martín MG, Bahar R, Maxfield AL, Ament ME, Busuttil RW.
    Transplantation; 1998 Dec 27; 66(12):1604-11. PubMed ID: 9884246
    [Abstract] [Full Text] [Related]

  • 12. Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy.
    Darenkov IA, Marcarelli MA, Basadonna GP, Friedman AL, Lorber KM, Howe JG, Crouch J, Bia MJ, Kliger AS, Lorber MI.
    Transplantation; 1997 Sep 27; 64(6):848-52. PubMed ID: 9326409
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
    San-Juan R, Comoli P, Caillard S, Moulin B, Hirsch HH, Meylan P, ESCMID Study Group of Infection in Compromised Hosts.
    Clin Microbiol Infect; 2014 Sep 27; 20 Suppl 7():109-18. PubMed ID: 24475976
    [Abstract] [Full Text] [Related]

  • 14. The IPTA Nashville Consensus Conference on Post-Transplant lymphoproliferative disorders after solid organ transplantation in children: III - Consensus guidelines for Epstein-Barr virus load and other biomarker monitoring.
    Preiksaitis J, Allen U, Bollard CM, Dharnidharka VR, Dulek DE, Green M, Martinez OM, Metes DM, Michaels MG, Smets F, Chinnock RE, Comoli P, Danziger-Isakov L, Dipchand AI, Esquivel CO, Ferry JA, Gross TG, Hayashi RJ, Höcker B, L'Huillier AG, Marks SD, Mazariegos GV, Squires J, Swerdlow SH, Trappe RU, Visner G, Webber SA, Wilkinson JD, Maecker-Kolhoff B.
    Pediatr Transplant; 2024 Feb 27; 28(1):e14471. PubMed ID: 37294621
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder.
    Green M, Michaels MG.
    Am J Transplant; 2013 Feb 27; 13 Suppl 3():41-54; quiz 54. PubMed ID: 23347213
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes.
    Lindsay J, Othman J, Heldman MR, Slavin MA.
    Curr Opin Infect Dis; 2021 Dec 01; 34(6):635-645. PubMed ID: 34751183
    [Abstract] [Full Text] [Related]

  • 17. The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation.
    Green M, Reyes J, Webber S, Rowe D.
    Transpl Infect Dis; 2001 Jun 01; 3(2):97-103. PubMed ID: 11395975
    [Abstract] [Full Text] [Related]

  • 18. A Focused Review of Epstein-Barr Virus Infections and PTLD in Pediatric Transplant Recipients: Guidance From the IPTA and ECIL Guidelines.
    Yamada M, L'Huillier AG, Green M.
    J Pediatric Infect Dis Soc; 2024 Feb 28; 13(Supplement_1):S31-S38. PubMed ID: 38417085
    [Abstract] [Full Text] [Related]

  • 19. Evidence of Epstein-Barr virus heterogeneous gene expression in adult lung transplant recipients with posttransplant lymphoproliferative disorder.
    Zaffiri L, Frankel C, Bush EJ, Neely ML, Pavlisko EN, Mokrova IL, Luftig MA, Palmer SM.
    J Med Virol; 2021 Aug 28; 93(8):5040-5047. PubMed ID: 33704812
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.